AXL and sarcoma: Here, we assessed that AXL is highly expressed among a variety of sarcomas, confirming previous data performed on primary sarcoma samples [20,22,31,32,62,63] and representing a promising target for the development of innovative immunotherapeutic approaches, especially in chemo-refractory disease.